Decrease of Deleted in Malignant Brain Tumour‐1 (DMBT‐1) expression is a crucial late event in intrahepatic cholangiocarcinoma
暂无分享,去创建一个
A. Poustka | Y. Jan | K. Tsuneyama | Y. Nimura | Y. Nakanuma | M. Sasaki | T. Yeh | A. Ishikawa | J. Mollenhauer | K. Oda | M.‐F. Chen | S. Huang
[1] T. Terada,et al. Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers. , 2008, Liver.
[2] A. Poustka,et al. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. , 2001, Cancer research.
[3] Y. Jan,et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.
[4] L. Thim,et al. Isolation and characterization of putative trefoil peptide receptors , 2000, Regulatory Peptides.
[5] H. S. Kim,et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. , 2000, Gastroenterology.
[6] A. Poustka,et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. , 2000, Cancer research.
[7] A. Sakurada,et al. Expression of the DMBT1 Gene Is Frequently Suppressed in Human Lung Cancer , 1999, Japanese journal of cancer research : Gann.
[8] J. Minna,et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. , 1999, Cancer research.
[9] K. Mafune,et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers , 1999, British Journal of Cancer.
[10] Y. Kim,et al. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction , 1998, Hepatology.
[11] Jan Mollenhauer,et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.
[12] E. Schlaepfer,et al. Improved In Situ Hybridization to HIV with RNA Probes Derived from PCR Products , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] Y. Kim,et al. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study , 1996, Hepatology.
[14] P. Chambon,et al. Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.
[15] T. Terada,et al. Intrahepatic peribiliary glands of humans. II. Pathological spectrum , 1994, Journal of gastroenterology and hepatology.
[16] 勝彦 齋藤,et al. ヒト肝内胆管癌の株化(CCKS1)樹立 , 1993 .
[17] Y. Nakanuma,et al. Expression of blood group‐related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases , 1989, Hepatology.
[18] T. Terada,et al. Pathologic features of hepatolithiasis in Japan. , 1988, Human pathology.
[19] D. V. van Thiel,et al. Pregnancy-Associated Sex Steroids and Their Effects on the Liver , 1987, Seminars in liver disease.
[20] T. Terada,et al. Are hepatolithiasis and cholangiocarcinoma aetiologically related? , 1985, Virchows Archiv A.
[21] M. Kojiro,et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy‐proven cases , 1977, Cancer.
[22] C. Ker,et al. Hepatolithiasis in East Asia retrospective study , 2005, Digestive Diseases and Sciences.
[23] T. Terada,et al. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths , 2005, Virchows Archiv A.